3344-19-2

Usage

InChI:InChI=1/C14H20O3/c1-5-16-13(15)10-17-12-8-6-11(7-9-12)14(2,3)4/h6-9H,5,10H2,1-4H3

Upstream product

• 64-17-5 ethanol 
• 3926-62-3 sodium monochloroacetic acid 
• 5787-50-8 sodium 4-tert-butylphenolate 
• 623-73-4 diazoacetic acid ethyl ester 
• 98-54-4 para-tert-butylphenol 
• 105-36-2 ethyl bromoacetate 
• 105-39-5 chloroacetic acid ethyl ester 

Downstream Products

• 1234-10-2 4-tert.-Butyl-phenoxyessigsaeure-<2-diaethylamino-aethylamid> 
• 75843-50-4 4-(tert-butyl)phenoxyacetic acid hydrazide 
• 1798-04-5 (4-tert-butylphenoxy)acetic acid 
• 301690-20-0 3-[2-(4-tert-butylphenoxy)acetylamino]benzoic acid methyl ester 
• 316128-55-9 2-(4-tert-butylphenoxy)-N-(benzothiazol-2-yl)acetamide 
• 1415560-93-8 C₂₄H₂₅N₃O₃ 
• 1258882-34-6 NC-Phe-OH 
• 1258882-33-5 C₂₂H₂₇NO₄ 

Relevant academic research and scientific papers

Structure and spectroscopic characteristics of 4-tert-butylphenoxyacetylhydrazones of arylaldehydes

By reaction of 4-tert-butylphenoxyacetylhydrazide with aromatic aldehydes and acetone a new series of 4-tert-butylphenoxyacetylhydrazones was synthesized. The structural peculiarities of the investigated molecules have been determined by means of X-ray analysis and IR spectroscopy. The diagnostically important IR spectral criteria required for the conformational analysis of acethylhydrazones have been considered. It was established that the 4-tert-butylphenoxyacetylhydrazide in condensed phase exists only as a ZN-C(O)-conformer. Its derivatives exist as EN-C(O) and ZN-C(O)-forms. As a rule, the prevalence of ZN-C(O)-form has been observed in CCl4 solutions. The structure of investigated compounds is also determined by a system of inter- and intramolecular hydrogen bonds. The energy of hydrogen bonds was estimated.

Small molecule compound and application and composition thereof

The invention discloses a small molecule compound and application and a composition thereof, and the application of the small molecule compound is specifically as follows: 4-((2-(4-(tert-butyl)phenoxy)acetyl)glycyl)phenylbenzo[d] [1,3]dioxane-5-carboxylic ester, or pharmaceutically, healthcare or food acceptable salt or ester or derivative thereof, or a mixture thereof for preparing substances for treating tumors, inhibiting tumor cell growth and/or inducing tumor cell apoptosis, and the composition contains: (1) a compound 4-((2-(4-(tert-butyl)phenoxy)acetyl)glycyl)phenylbenzo [d][1, 3]dioxane-5-carboxylic acid esters, or pharmaceutically, healthcare or food acceptable salts or esters or derivatives thereof, or mixtures thereof; (2) an apoptosis-causing drug; and (3) a carrier or excipient acceptable in pharmacy, health care science or food science.

Synthesis and larvicidal activity of 1,3,4-oxadiazole derivatives containing a 3-chloropyridin-2-yl-1H-pyrazole scaffold

Abstract: A new series of 1,3,4-oxadiazole derivatives with a 3-chloropyridin-2-yl-1H-pyrazole moiety was designed, synthesized, and characterized. The results of bioassay against Helicoverpa armigera and Plutella xylostella indicated that some of the synthesized compounds showed remarkable larvicidal activity. In particular, the LC50 values of the most active compounds against P. xylostella were 46.5, 23.9, and 13.9?mg/dm3, and against Helicoverpa armigera were 88.3 and 69.5?mg/dm3, the latter being slightly better than commercial chlorpyrifos (LC50 103.77?mg/dm3). Preliminary SAR was also discussed. Graphical abstract: [Figure not available: see fulltext.].

Synthesis, Nematicidal Activity, and 3D-QSAR of Novel 1,3,4-Oxadiazole/ Thiadiazole Thioether Derivatives

Forty one novel 1,3,4-oxadiazole/thiadiazole thioether derivatives containing phenoxy moiety were designed and synthesized. Bioassay demonstrated that some of them showed remarkable activities against Tylenchulus semipenetrans in vitro and in vivo. Compounds 20, 21, 35 and 39 showed excellent lethal activities after treatment for 48?h in vitro, with LC50 values of 13.4?±?1.8, 11.7?±?2.5, 13.7?±?2.4 and 13.3?±?1.1?mg·L–1, respectively, which were obviously superior to fosthiazate (49.1?±?2.8?mg·L–1) and avermectin (26.6?±?2.3?mg·L–1). Compound 21 can effectively control the citrus nematode disease caused by T. semipenetrans at 200?mg·L–1 in vivo with (68?±?3)% inhibitory effect, which was even better than that of avermectin ((63?±?2)%). The CoMFA and CoMSIA models of three-dimensional quantitative structure-activity relationships (3D-QSARs) were established. The compound 33 was designed based on the 3D-QSAR models with more vigorous nematicidal activities in vitro (LC50?=?9.8?±?1.4?mg·L–1) and in vivo ((70?±?5)%). These results demonstrated that compound 33 can be considered as a potential nematicide.

Methyl 3-(3-(4-(2,4,4-Trimethylpentan-2-yl)phenoxy)-propanamido)benzoate as a Novel and Dual Malate Dehydrogenase (MDH) 1/2 Inhibitor Targeting Cancer Metabolism

Previously, we reported a hypoxia-inducible factor (HIF)-1 inhibitor LW6 containing an (aryloxyacetylamino)benzoic acid moiety inhibits malate dehydrogenase 2 (MDH2) using a chemical biology approach. Structure-activity relationship studies on a series of (aryloxyacetylamino)benzoic acids identified selective MDH1, MDH2, and dual inhibitors, which were used to study the relationship between MDH enzyme activity and HIF-1 inhibition. We hypothesized that dual inhibition of MDH1 and MDH2 might be a powerful approach to target cancer metabolism and selected methyl-3-(3-(4-(2,4,4-trimethylpentan-2-yl)phenoxy)propanamido)-benzoate (16c) as the most potent dual inhibitor. Kinetic studies revealed that compound 16c competitively inhibited MDH1 and MDH2. Compound 16c inhibited mitochondrial respiration and hypoxia-induced HIF-1α accumulation. In xenograft assays using HCT116 cells, compound 16c demonstrated significant in vivo antitumor efficacy. This finding provides concrete evidence that inhibition of both MDH1 and MDH2 may provide a valuable platform for developing novel therapeutics that target cancer metabolism and tumor growth.

Highly selective and efficient extraction of two Pb2+ ions with a p-tert-butylcalix[6]arene hexacarboxylic acid ligand: An allosteric effect in extraction

Solvent extraction behavior of p-tert-butylcalix[6]arene hexacarboxylic acid towards Pb2+ and other divalent transition metal ions has been studied to investigate the selectivity, extraction mechanism, stoichiometry of complexation and composition of the complex in the organic phase. Extractability and selectivity of the cyclic ligand were analyzed in comparison with the acyclic analog. The macrocyclic effect was genuinely operative and the size-match effect was the governing factor for cation selectivity. Accordingly, the cyclic ligand selectively extracted the Pb2+ ion in a pH range fairly more acidic than the acyclic ligand. The cations were extracted by ion exchange mechanism, and the electroneutral complexes were resulted by the exchange of two protons for a divalent cation. A molecule of p-tert-butyl calix[6]arene hexacarboxylic acid ligand extracted two Pb2+ ions. One Pb2+ was extracted due to the size-fit effect inside the hydrophilic cavity of calix[6]arene composed by phenoxy and carbonyl oxygen atoms. The macrocyclic ring inversion was obstructed due to guest encapsulation, and the encapsulated Pb2+ ion acted as a template for aggregation of the carboxyl groups. This binding event caused a positive allosteric effect and led to the extraction of the second Pb2+ ion at the aggregated functional group site.

Discovery of a novel series of benzimidazole derivatives as diacylglycerol acyltransferase inhibitors

A novel series of benzimidazole derivatives was prepared and evaluated for their diacylglycerol acyltransferase (DGAT) inhibitory activity using microsome from rat liver. Among the newly synthesized compounds, furfurylamine containing benzimidazole carboxamide 10j showed the most potent DGAT inhibitory effect (IC50= 4.4 μM) and inhibited triglyceride formation in HepG2 cells. Furthermore, compound 10j reduced body weight gain of Institute of Cancer Research mice on a high-fat diet and decreased levels of total triglyceride, total cholesterol, and LDL-cholesterol in the blood accompanied with a significant increase in HDL-cholesterol level.

Photo-fluorodecarboxylation of 2-aryloxy and 2-aryl carboxylic acids

Coming to light: The title reaction simply requires an aqueous alkaline solution of Selectfluor and light. The method is inexpensive and effective for a wide range of neutral and electron-poor 2-aryloxy and 2-aryl acetic acids to provide fluoromethyl ethers (see scheme) and benzyl fluorides, respectively. The mechanism most likely proceeds through an initial aryl excitation with a subsequent single-electron transfer. Copyright

1,3-diamido-calix[4]arene conjugates of amino acids: Recognition of -COOH side chain present in amino acids, peptides, and proteins by experimental and computational studies

Lower rim 1,3-diamido conjugates of calix[4]arene have been synthesized and characterized, and the structures of some of these have been established by single crystal XRD. The amido-calix conjugates possessing a terminal -COOH moiety have been shown to exhibit recognition toward guest molecules possessing -COOH moiety, viz., Asp, Glu, and reduced and oxidized glutathione (GSH, GSSG), by switch-on fluorescence in aqueous acetonitrile and methanol solutions when compared to the control molecules via forming a 1:1 complex. The complex formed has been shown by mass spectrometry, and the structural features of the complexes were derived on the basis of DFT computations. The association constants observed for the recognition of Asp/Glu by Phe-calix conjugate, viz., 532/676 M-1, are higher than that reported for the recognition of Val, Leu, Phe, His, and Trp (16-63 M-1) by a water-soluble calixarene (Arena, G., et al. Tetrahedron Lett. 1999, 40, 1597). For this recognition, there should be a free -COOH moiety from the guest molecule. AFM, SEM, and DLS data exhibited spherical particles with a hundred-fold reduction in the size of the complexes when compared to the particles of the precursors. These spherical particles have been computationally modeled to possess hexameric species reminiscent of the hexameric micellar structures shown for a Ag+ complex of a calix[6]arene reported in the literature (Houmadi, S., et al. Langmuir 2007, 23, 4849). Both AFM and TEM studies demonstrated the formation of nanospheres in the case of GSH-capped Ag nanoparticles in interaction with the amido-calix conjugate that possesses terminal -COOH moiety. The AFM studies demonstrated in this paper have been very well applied to albumin proteins to differentiate the aggregational behavior and nanostructural features exhibited by the complexes of proteins from those of the uncomplexed ones. To our knowledge, this is the first report wherein a amido-calix[4]arene conjugate and its amino acid/peptide/protein complexes have been differentiated on the basis of spectroscopy and microscopy studies followed by species modeling by computations.

Boron-containing phenoxyacetanilide derivatives as hypoxia-inducible factor (HIF)-1α inhibitors

A series of boron-containing phenoxyacetanilide derivatives 8a-f, 9a-f, 15, and 16 were synthesized as hypoxia-inducible factor (HIF)-1α inhibitors. Among the compounds synthesized, carboranylphenoxyacetanilide 16 (GN26361) was found to be a potent inhibitor against HIF-1α accumulation under hypoxic conditions and inhibited the hypoxia-induced HIF-1 transcriptional activity in HeLa cells (IC50 = 0.74 μM). Compound 16 suppressed hypoxia-induced HIF-1α accumulation and vascular endothelial growth factor mRNA expression in a concentration-dependent manner without affecting the expression of HIF-1α mRNA.